Scienture Holdings Inc
SCNX1.930USD
+0.020+1.05%
Horário de mercado （ET）Cotações atrasadas em 15 min
24.15MValor de mercado
PerdaP/L TTM
Mais detalhes de Scienture Holdings Inc Empresa
Scienture Holdings, Inc., formerly TRxADE Health, Inc., is a comprehensive health services and pharmaceutical product company focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs, optimize the prescription journey and patient engagement in the United States. It operates through Scienture, LLC and Integra Pharma Solutions, LLC. Scienture, LLC is a branded specialty pharmaceutical company. Its assets in development are across therapeutics areas, indications and cater to different market segments. Its products include SCN - 102 (Cardiovascular), SCN - 104 (CNS-Pain), SCN - 105 (CNS), SCN - 106 (Cardiovascular) and SCN - 107 (Pain). Integra Pharma Solutions, LLC is the pharmaceutical supplier of choice for healthcare organizations of all sizes. Its expertise in the distribution of products extends to all healthcare markets including government organizations, hospitals, clinics, and independent pharmacies nationwide.
Informações da empresa
Código da empresaSCNX
Nome da EmpresaScienture Holdings Inc
Data de listagemFeb 18, 2020
CEODr. Narasimhan Mani
Número de funcionários14
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 18
Endereço- -
Cidade- -
Bolsa de valoresNASDAQ Capital Market Consolidated
País- -
Código postal- -
Telefone- -
Site- -
Código da empresaSCNX
Data de listagemFeb 18, 2020
CEODr. Narasimhan Mani
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Director
President, Co-Chief Executive Officer, Director
1.42M
--
Dr. Shankar Hariharan, Ph.D.
Dr. Shankar Hariharan, Ph.D.
Executive Chairman of the Board, Co-Chief Executive Officer
Executive Chairman of the Board, Co-Chief Executive Officer
--
--
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
--
--
Mr. Mayur Doshi
Mr. Mayur Doshi
Independent Director
Independent Director
--
--
Mr. Donald G. Fell
Mr. Donald G. Fell
Independent Director
Independent Director
--
--
Mr. Eric Sherb
Mr. Eric Sherb
Chief Financial Officer
Chief Financial Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Narasimhan Mani
Dr. Narasimhan Mani
President, Co-Chief Executive Officer, Director
President, Co-Chief Executive Officer, Director
1.42M
--
Dr. Shankar Hariharan, Ph.D.
Dr. Shankar Hariharan, Ph.D.
Executive Chairman of the Board, Co-Chief Executive Officer
Executive Chairman of the Board, Co-Chief Executive Officer
--
--
Mr. Subbarao Jayanthi
Mr. Subbarao Jayanthi
Independent Director
Independent Director
--
--
Mr. Mayur Doshi
Mr. Mayur Doshi
Independent Director
Independent Director
--
--
Mr. Donald G. Fell
Mr. Donald G. Fell
Independent Director
Independent Director
--
--
Mr. Eric Sherb
Mr. Eric Sherb
Chief Financial Officer
Chief Financial Officer
--
--
Detalhamento da receita
Moeda: USDAtualizado em: dom, 6 de jul
Moeda: USDAtualizado em: dom, 6 de jul
FY2024
Sem dados
Por RegiãoUSD
Nome
Receita
Proporção
United States
136.64K
0.00%
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: qua, 2 de jul
Atualizado em: qua, 2 de jul
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Hariharan (Shankar Ph.D.)
17.09%
Mani (Narasimhan)
10.20%
Ajjarapu (Surendra K)
1.51%
Patel Prashant
1.27%
Doshi (Mayur Mansukhlal)
0.48%
Other
69.44%
Investidores
Investidores
Proporção
Hariharan (Shankar Ph.D.)
17.09%
Mani (Narasimhan)
10.20%
Ajjarapu (Surendra K)
1.51%
Patel Prashant
1.27%
Doshi (Mayur Mansukhlal)
0.48%
Other
69.44%
Tipos de investidores
Investidores
Proporção
Individual Investor
30.81%
Hedge Fund
0.61%
Investment Advisor
0.43%
Investment Advisor/Hedge Fund
0.23%
Other
67.92%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
28
4.45M
32.09%
+15.20K
2025Q1
32
4.45M
33.93%
+9.47K
2024Q4
36
4.62M
68.10%
+3.89M
2024Q3
36
1.01M
65.38%
+269.18K
2024Q2
37
1.00M
67.44%
+530.62K
2024Q1
34
476.38K
36.25%
+95.67K
2023Q4
35
386.59K
47.32%
+20.29K
2023Q3
38
376.26K
55.40%
-6.85K
2023Q2
38
402.57K
59.37%
+44.99K
2023Q1
42
365.94K
58.68%
-79.79K
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Hariharan (Shankar Ph.D.)
2.37M
18.07%
--
--
Jan 27, 2025
Mani (Narasimhan)
1.42M
10.79%
--
--
Jan 27, 2025
Ajjarapu (Surendra K)
210.10K
1.6%
--
--
Jan 27, 2025
Patel Prashant
176.69K
1.35%
--
--
Jan 27, 2025
Doshi (Mayur Mansukhlal)
66.45K
0.51%
--
--
Jan 27, 2025
Armistice Capital LLC
65.50K
0.5%
+36.65K
+127.04%
Dec 31, 2023
Susquehanna International Group, LLP
37.41K
0.29%
+37.41K
--
Mar 31, 2025
Fell (Donald G.)
35.16K
0.27%
--
--
Jan 27, 2025
Geode Capital Management, L.L.C.
32.16K
0.25%
+11.60K
+56.41%
Mar 31, 2025
Millennium Management LLC
14.68K
0.11%
-19.30K
-56.80%
Mar 31, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Jun 21, 2023
Merger
15<1
Jun 21, 2023
Merger
15<1
Jun 21, 2023
Merger
15<1
Jun 21, 2023
Merger
15<1
Data
Tipo
Proporção
Jun 21, 2023
Merger
15<1
Jun 21, 2023
Merger
15<1
Jun 21, 2023
Merger
15<1
Jun 21, 2023
Merger
15<1
